The Minimally Invasive Image-Guided Intervention Center (MAGIC) is part of the Department of Radiology and Nuclear Medicine of Radboud University Medical Center in Nijmegen, the Netherlands and is chaired by prof. dr. Jurgen Fütterer.
The group has its roots in MRI-guided prostate treatment, and we have expanded to CT-, US-, and MR- image guided oncologic interventions, as for example biopsy of prostate, bone and liver; (non-) thermal ablations of pancreas, liver, kidney, prostate and vascular malformations. Supplementary we focus on nuclear interventions with Holmium particles; intra-operative navigation; robotics; ex-vivo imaging; clinical decision support; and perfusion and vascular interventions. The interventions are developed and performed in close collaboration with the Medical Innovation and Technology expert Center.
It is our goal to have a significant impact on healthcare by bringing our technology to daily practice. We are therefore fully equipped to develop, implement and improve image-guided interventions for clinical practice.
Last week, the MAGIC group met with Alan Goh and Hu Xiaoxiang from NDR Medical Technology. This Singapore-based startup has developed a robotic system with artificial intelligence and image processing for automated needle targeting (ANT). The device intends to aid surgeons and interventional radiologists by providing a precise needle trajectory with integration of medical images, allowing for increased accuracy of needle placement in an intended target and a shorter procedure time. This technology can be of use in a wide range of interventions, for example in targeted liver biopsy, ablation of liver tumors but also in percutaneous nephrolithotomy or placement of nephrostomy catheter. We successfully performed a preliminary experiment in the CT environment using a phantom of an abdomen with several targets. Based on this first experience, further improvements can be made in the appliance of ANT with CT-guidance. We hope to collaborate again with NDR medical technology in the near future.